Abstract | BACKGROUND:
Atrial fibrillation is a frequently occurring arrhythmia after thoracic operations. Preventive strategies for this complication have been extensively evaluated after cardiac operations. METHODS: We performed a prospective, open randomized study, comparing intravenous verapamil and placebo in 199 patients after pneumonectomy or lobectomy at the University Hospital of Leuven. Verapamil was administered as a bolus of 10 mg over 2 minutes followed by a 30-minute infusion of 0.375 mg/min and then 0.125 mg/min for 3 days. The patients were continuously monitored in the postoperative intensive care unit. RESULTS: CONCLUSIONS: If tolerated, continuous intravenous verapamil infusion showed only a modest prophylactic efficacy for the occurrence of atrial fibrillation after lung operations. In the dose employed the verapamil infusion was accompanied with a high incidence of side effects necessitating interruption of the therapy.
|
Authors | W Van Mieghem, G Tits, K Demuynck, L Lacquet, G Deneffe, T Tjandra-Maga, M Demedts |
Journal | The Annals of thoracic surgery
(Ann Thorac Surg)
Vol. 61
Issue 4
Pg. 1083-5; discussion 1086
(Apr 1996)
ISSN: 0003-4975 [Print] Netherlands |
PMID | 8607661
(Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Anti-Arrhythmia Agents
- Verapamil
- Amiodarone
|
Topics |
- Amiodarone
(adverse effects, therapeutic use)
- Anti-Arrhythmia Agents
(adverse effects, blood, therapeutic use)
- Atrial Fibrillation
(epidemiology, etiology, prevention & control)
- Bradycardia
(chemically induced, epidemiology)
- Humans
- Hypotension
(chemically induced, epidemiology)
- Incidence
- Middle Aged
- Pneumonectomy
(adverse effects, statistics & numerical data)
- Postoperative Complications
(epidemiology, etiology, prevention & control)
- Prospective Studies
- Respiratory Distress Syndrome
(chemically induced, epidemiology)
- Verapamil
(adverse effects, blood, therapeutic use)
|